fight baldness

Two oral drugs—approved by the FDA for inflammation in blood diseases (ruxolitinib) and rheumatoid arthritis (tofacitinib)—grow hair when slathered on skin, report surprised Columbia University researchers in Science Advances. If future work supports this, the hair-loss community could have new...